Boehringer Ingelheim and Zealand Pharma Receive FDA Fast Track Designation for Investigational Treatment for NASH
Boehringer Ingelheim and Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078) today announced that the US Food and Drug Administration (FDA) has granted Fast Track Designation to the GLP-1/glucagon dual agonist BI 456906 for adults with non-alcoholic steatohepatitis (NASH). The Fast Track Designation facilitates the development and expedites the review of new therapies to treat serious conditions and fill an unmet medical need. BI 456906 is currently being evaluated in a Phase II study in adults with NASH and liver fibrosis (F2/F3) with and without diabetes.
“The FDA Fast Track Designation for our dual agonist is an important step forward in addressing the high unmet medical need among the up to 444 million adults estimated to be living with NASH,” said Waheed Jamal, MD, Corporate Vice President and Head of CardioMetabolic Medicine, Boehringer Ingelheim. “Together with our partner Zealand Pharma, we look forward to working closely with the FDA as we explore the potential of the GLP-1/glucagon agonist to improve outcomes for adults with NASH.”
“Boehringer Ingelheim and Zealand Pharma are committed to delivering innovative solutions that address public health challenges of cardiometabolic diseases, including NASH,” said Adam Steensberg, Executive Vice President and Chief Medical Officer at Zealand Pharma. “By combining Boehringer Ingelheim’s expertise in drug development in the cardio-metabolic area with our strength in the discovery of innovative peptide-based medicines, we have the potential to bring forward a novel therapy option in an area with limited available treatments.”
The GLP-1/glucagon compound derived from the natural gut hormone oxyntomodulin activates both the GLP-1 and glucagon receptors that are critical to controlling metabolic functions. The dual agonist BI 456906 has the potential to be a new, once-weekly treatment that may offer therapeutically relevant benefits compared to currently available treatments. It is also being investigated as a potential treatment option for adults living with diabetes and for adults living with obesity. It is part of Boehringer Ingelheim’s research and development portfolio in the cardiometabolic disease areas.
Please click on the following link for ‘Notes to Editors’:
http://www.boehringer-ingelheim.com/press-release/fast-track-designation-nash
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210602005582/en/
Contact information
Media Contacts
Boehringer Ingelheim
Dr. Birgit Leimer
Product Communications Manager
Boehringer Ingelheim Corporate Center GmbH
Media + PR
E-Mail: press@boehringer-ingelheim.com
Zealand Pharma Investor Relations
Claudia Styslinger
Argot Partners
E-Mail: investors@zealandpharma.com
Zealand Pharma Media Relations
David Rosen
Argot Partners
E-Mail: media@zealandpharma.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
I-care Becomes a Unicorn23.12.2025 10:45:00 CET | Press Release
I-care announces the completion of a €20 million fundraising and refinancing operation, carried out as a round reserved for existing shareholders and employees. Based on this operation, the group's valuation reaches €1 billion, making I-care a unicorn. "Becoming a unicorn is a symbolic milestone. To achieve this, we chose to invest before reaping the rewards: we bet on AI when few believed in it, we prioritized R&D, and we built our own production unit. These choices were sometimes difficult, but they were essential to staying ahead of the game. Today, our results confirm that this strategy was the right one," explains Fabrice Brion, CEO of I-care. This fundraising round is the first step in a three-phase development plan. Following the “Eau Rouge” operation in 2022, which enabled I-care to become the world leader in predictive maintenance, the company has now set itself a clear objective: to accelerate its growth in order to increase its market share. The second phase of this plan wil
Liquid Reply Joins the Agentic AI Foundation (AAIF) to Advance Open, Trusted Agentic AI23.12.2025 10:00:00 CET | Press Release
Liquid Reply, specialising in platform engineering and cloud-native technologies within the Reply Group, today announced that it has joined the Agentic AI Foundation (AAIF). The newly established foundation was launched under the auspices of the Linux Foundation and provides a neutral, open governance framework for the development of agent-based AI systems. Members collaborate transparently to develop tools, protocols, and specifications that remain available as open-source resources for the global community. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223604862/en/ Through its membership, Liquid Reply will engage the AAIF community and actively support the establishment of open standards for the next generation of AI-powered applications. By joining the AAIF, Liquid Reply reinforces its commitment to open-source and community-driven innovation, and supports the creation of shared technical foundations for the responsi
Rajant Kinetic Mesh® Proves Subterranean Connectivity During NATO ARRC “Ex AVENGER TRIAD 25” Exercise23.12.2025 10:00:00 CET | Press Release
Rajant Corporation, the exclusive provider of peer to peer, private Kinetic Mesh® networks consisting of BreadCrumb® wireless nodes powered by InstaMesh® routing, today announced the successful completion of a subterranean communications trial during NATO Allied Rapid Reaction Corps’ (ARRC) primary exercise of the year, Ex AVENGER TRIAD 25, which was conducted in October–November 2025. During the exercise, Rajant provided the communications equipment that delivered robust underground bandwidth in a retired mine in England. The Rajant network operated as a transport-agnostic, multi-bearer networking overlay that unified disparate communication technologies into a single resilient transport fabric, integrating cleanly with existing network transports and mission systems. ARRC users and the British Army’s 22 Signal Regiment recognized the utility of the approach and identified avenues to exploit the capability further, most notably a wireless subterranean headquarters concept, while also
Spain’s CESGA Selects IQM and Telefónica to Deploy Advanced Quantum Computing Infrastructure23.12.2025 09:53:00 CET | Press Release
IQM Quantum Computers, the global leader in deployed, on-premises computers, and Telefónica, a global telecommunications provider, have joined forces to sign a purchase agreement with the Galician Supercomputing Center (CESGA) to install two full-stack quantum computers in Spain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223742835/en/ Spain’s CESGA selects IQM and Telefónica to deploy advanced quantum computing infrastructure Under the agreement, IQM will deliver and install a 54-qubit IQM Radiance, designed for integration into high-performance computing centres, together with a 5-qubit IQM Spark system dedicated to education. The systems are scheduled for delivery by June 2026. The deployment will expand CESGA’s advanced computing capabilities and strengthen its role as a key national and European research infrastructure. The systems will be used by the scientific community and made accessible to leading companies
HARMAN to Acquire ZF’s ADAS Business23.12.2025 09:00:00 CET | Press Release
HARMAN International, a global leader in automotive technology and lifestyle audio, and a wholly-owned subsidiary of Samsung Electronics Co., Ltd., today announced that it has entered into a definitive agreement to acquire the Advanced Driver Assistance Systems (ADAS) business of ZF Group, comprising leading automotive compute solutions, smart cameras, radars and ADAS software functions. The transaction is valued at €1.5 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223683768/en/ Mathias Miedreich, CEO of ZF Group; Young Sohn, Chairman of the Board of Directors, HARMAN and Senior Advisor, Samsung Electronics; and Christian Sobottka, Chief Executive Officer and President, Automotive Division, HARMAN, sign a definitive agreement for HARMAN to acquire ZF’s ADAS business – strengthening HARMAN’s leadership in software-defined vehicles and advancing a unified safety-to-experience platform for automakers worldwide. A
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom